Potassium content of irradiated packed red blood cells in different storage media: is there a need for additive

H El Kenz1, F Corazza, P Van Der Linden

  • 1Brugmann University Hospital Centre, Queen Fabiola University Children Hospital Blood Bank, Brussels, Belgium.

Insights

Gamma irradiation of packed red blood cells (PRBCs) in AS-3 medium increases potassium levels. Irradiated AS-3 PRBCs older than 7 days are not recommended for rapid neonatal transfusions due to TA-GVHD risks.

Area of Science:

  • Transfusion Medicine
  • Blood Banking
  • Neonatal Hematology

Background:

  • Gamma irradiation prevents transfusion-associated graft-versus-host disease (TA-GVHD).
  • Irradiation increases supernatant potassium in packed red blood cells (PRBCs) stored in CPDA-1 and SAGM solutions.
  • Data on irradiated PRBCs in AS-3 medium, a neonatal-safe solution, are lacking.

Purpose of the Study:

  • To evaluate hemolysis and potassium release from irradiated PRBCs stored in AS-3 medium.
  • To compare these findings with existing data for SAGM and CPDA-1 PRBCs.
  • To inform transfusion guidelines for neonates and infants.

Main Methods:

  • Packed red blood cells (PRBCs) were stored in AS-3 medium.
  • PRBCs were gamma-irradiated.
  • Hemolysis and potassium levels in the supernatant were measured at various time points post-irradiation.
  • Results were compared with published data for PRBCs in SAGM and CPDA-1.

Main Results:

  • Irradiated AS-3 PRBCs showed increased potassium release over time.
  • Potassium levels exceeded safety thresholds for neonatal transfusion after 7 days post-irradiation.
  • Hemolysis levels remained within acceptable limits.

Conclusions:

  • Irradiated PRBCs stored in AS-3 medium for over 7 days post-irradiation pose a risk of hyperkalemia in neonates.
  • These PRBCs should not be used for massive or rapid transfusions in neonates and infants.
  • Further research is needed to optimize storage and irradiation protocols for neonatal transfusions.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...